Drug wholesaler AmerisourceBergen Corp reported quarterly earnings that topped expectations, helped by higher sales of specialty generics. The company also raised its 2011 earnings outlook to $2.41-$2.49 a share, from its previous view of $2.31-$2.41 a share. Analysts were expecting $2.41 a share on revenue of $80.2 billion, according to Thomson Reuters I/B/E/S. Net earnings rose 6 percent to $214.4 million, or 77 cents a share, in the second quarter, from $181 million, or 63 cents a share, a year ago.
Source
